Predicting the Probability of Experiencing Clinically Significant Drug–Drug Interactions Involving Boceprevir-Containing Hepatitis C Therapy Among Patients Coinfected with Hepatitis C and HIV

Benzer Materyaller

• Prevalence and Predictors of Important Telaprevir Drug Interactions Among Patients Coinfected With Hepatitis C and Human Immunodeficiency Virus
  Yazar:: Patel, Nimish, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients
  Yazar:: Patel, Nimish, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women
  Yazar:: Bernabucci, Veronica, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy
  Yazar:: Neukam, Karin, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Surveillance of HIV, Hepatitis B Virus, and Hepatitis C Virus in an Estonian Injection Drug–Using Population: Sensitivity and Specificity of Testing Syringes for Public Health Surveillance
  Yazar:: Uusküla, Anneli, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)